Seòmar agus comataidhean

I refer the member to the answer to question S6W-41944 on 1 December 2025, Education Scotland are currently reviewing the curriculum in line with the Curriculum Improvement Cycle programme. As part of this review, work is taking place to review the place of financial education within the curriculum. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The engagement to date has included a series of collaborative sessions involving a broad range of practitioners, stakeholders, and academics, including representatives from the Money and Pensions Service, the Scottish Qualifications Authority, the Scottish Secondary Teachers’ Association, the National Association of Student Money Advisers, and Money Ready. These sessions have examined the current landscape of financial education, drawing on evidence-based research, and have initiated planning on how financial education might be effectively integrated into the Scottish curriculum to promote a coherent and equitable approach.

I refer the member to the answer to question S6W-41890 on 1 December 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The SMC | Scottish Medicines Consortium (SMC) appraisal is undertaken independently of Scottish Ministers and is based on the clinical and cost-effectiveness of newly licensed medicines at a population level, ensuring value for both the NHS in Scotland and taxpayers.

Following a submission for (a) elacestrant (Korserdu®), as a treatment for postmenopausal women, and men, with locally advanced or metastatic breast cancer, the SMC published ‘not recommended’ advice in November 2025, and (b) capivasertib (Truqap®), as a treatment for adult patients with locally advanced or metastatic breast secondary breast cancer, the SMC published ‘not recommended’ advice in October 2025.

In both cases, the submitting pharmaceutical companies did not present a sufficiently robust economic analysis to gain acceptance. The SMC would welcome a resubmission from both companies at any time.

Since May 2021, Ministerial oversight of the National Museums Scotland (NMS) has been led by the Minister for Europe and International Development until January 2022, then the Minister for Culture, Europe and International Development from January 2022 until May 2024. I took over Ministerial oversight of NMS in May 2024.

In that time period, I joined the NMS Board of Trustees pre-meeting session on 8 June 2022. Ministers and I have met when required with the Chief Executive as is normal convention for non-departmental public bodies.

The Scottish Government and Public Health Scotland continue to support NHS Highland and Highland HSCP to ensure consistent, safe and timely access to vaccination across the area under the new model. The detailed timetable is a matter for NHS Highland and Highland HSCP.

We are committed to ensuring that children and young people are equipped with the skills, knowledge and understanding to successfully navigate a world where AI permeates all aspects of society.

The current curriculum includes digital literacy which allows teachers to develop learners’ skills in the use of digital tools, including AI.

Work to consider and update all curriculum areas as part of the Curriculum Improvement Cycle, including Technologies, is underway. The Cycle will consider cross-curricular expectations, including digital literacy and political literacy and will involve input from a range of academic and industry experts, ensuring that our thinking reflects best practice in what is a fast moving and complex area.

In recognition of the challenges and opportunities that AI poses for teaching and learning, we have been pleased to provide funding to the University of Edinburgh to develop resources to support the teaching of AI across several subject areas.

Work also continues at pace to develop AI guidelines and guardrails for teachers on the ethical use of AI in schools. We hope to publish this in the coming months.

Ministers and officials consider a broad range of evidence of the potential impact of offshore wind activity on other marine-related sectors, including through the established and rigorous planning, licensing and consenting processes for offshore wind developments.

The SMC | Scottish Medicines Consortium (SMC) appraisal is undertaken independently of Scottish Ministers. Making decisions about whether or not to recommend that people should routinely have access to new medicines is a complex task, and the independent SMC bases its decisions on the best available evidence provided to it.

Where licensed medicines, such as elacestrant and capivasertib, are not routinely available on the NHS in Scotland, doctors can use the PACS Tier Two system to request access on a case-by-case basis. The cost of the medicine is not a decision-making criterion when considering PACS Tier Two applications.

I refer the member to the answer to question S6W-41902 on 1 December 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The Scottish Government has full confidence in NatureScot’s Chief Executive Officer and its Chair on the work being carried out by NatureScot in relation to gull management.

The Scottish Government and Scottish Ministers regularly meet with NatureScot on a range of issues, including gull management.